英国

我们是谁

  • 4 月 5, 2022
    BMS-986253与Nivolumab或Nivolumab加Ipilimumab联合治疗晚期癌症的研究
  • 4 月 5, 2022
    伊帕塞替联合阿特珠单抗的试验
  • 4 月 5, 2022
    肿瘤诊断精准免疫肿瘤学和体细胞靶向合理性（TAPISTRY）平台研究
  • 4 月 5, 2022
    Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck
  • 4 月 5, 2022
    iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer
  • 4 月 5, 2022
    Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
  • 4 月 5, 2022
    Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
  • 4 月 5, 2022
    An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
  • 4 月 5, 2022
    KRAS G12C突变晚期结直肠癌患者MRTX849联合西妥昔单抗与化疗的3期研究（KRYSTAL-10）
  • 4 月 5, 2022
    DCC-3014 对晚期肿瘤和腱鞘巨细胞瘤患者的研究